Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors-Reference-Cited by-同舟云学术

Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors

Published:2022-08-04 Issue:1 Volume:13 Page:970-981
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tahiri Andliena¹²³,Puco Katarina⁴,Naji Faris⁵,Kristensen Vessela N.¹²,Alfsen Glenny Cecilie¹⁶,Farkas Lorant¹⁶,Nilsen Frode S.¹⁷,Müller Stig¹⁷⁸,Oldenburg Jan¹⁴⁸,Geisler Jürgen¹⁴⁸

Affiliation:

1. Institute of Clinical Medicine, University of Oslo, Oslo, Norway

2. Department of Medical Genetics, Oslo University Hospital, Ullevål, Norway

3. Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway

4. Department of Oncology, Akershus University Hospital, Lørenskog, Norway

5. Pamgene International BV, ‘s-Hertogenbosch, The Netherlands

6. Department of Pathology, Akershus University Hospital, Lørenskog, Norway

7. Department of Urology, Akershus University Hospital, Lørenskog, Norway

8. These authors contributed equally to this work

Publisher

Impact Journals, LLC

Subject

Oncology

Reference38 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Bray;Eur J Cancer,2013

2. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Bray;Int J Cancer,2019

3. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study;Lundstam;World J Urol,2016

4. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma;Gibbs;Cell Rep,2018

5. Tumor biology and prognostic factors in renal cell carcinoma;Belldegrun;Oncologist,2011